Ashish Rukhaiyar &Amp; Reghu Balakrishnan

Stories by Ashish Rukhaiyar &Amp; Reghu Balakrishnan

Wellness firms in fund-raising mode to tap growth

Wellness firms in fund-raising mode to tap growth

Rediff.com   28 Sep 2011

Tapping opportunities in this growing industry, major players are expanding their business and raising funds through the public market or private equity route.

Gen-next boost to Cipla's growth pill

Gen-next boost to Cipla's growth pill

Rediff.com   14 Sep 2011

Samina Vaziralli, daughter of joint Managing Director M K Hamied, was inducted into the company management. Cipla joins the league of major companies such as Lupin, Wockhardt, Elder Pharma, Piramal Healthcare and JB Chemicals in this regard.

Pipavav Shipyard: Jhunjhunwala likely to buy stake

Pipavav Shipyard: Jhunjhunwala likely to buy stake

Rediff.com   6 Sep 2011

According to market sources, Jhunjhunwala will acquire a significant minority stake in Pipavav.

Pharmaceutical mega brand buyouts a sweet pill

Pharmaceutical mega brand buyouts a sweet pill

Rediff.com   2 Sep 2011

It may be Doktor Mom in Russia, or Farex in India.

Milestone directors to decide on new CEO soon

Milestone directors to decide on new CEO soon

Rediff.com   29 Aug 2011

Milestone was in an aggressive mode, by hiring more senior people to head its funds and launching new funds.

Hawkish RBI makes FIIs nervous

Hawkish RBI makes FIIs nervous

Rediff.com   28 Jul 2011

While FIIs remain bullish on India's long-term prospects, they feel the recent rate increases by RBI have put the markets at an additional risk in the near term and delayed the break out from the current range.

NSE, BSE to become facilitators for SME

NSE, BSE to become facilitators for SME

Rediff.com   13 Jul 2011

Both the main stock exchanges have set in motion a separate platform to generate more interest and more liquidity for the small and medium enterprises (SME) segment.

Core Projects may buy Rs 350-cr Andheri property

Core Projects may buy Rs 350-cr Andheri property

Rediff.com   11 Jul 2011

The saga of buying out high-end office space in Mumbai continues. In a latest development, Mumbai-based education company, Core Projects and Technologies, is in talks with the leading plastic goods maker Supreme Industries to buy out the office property developed by the latter in the Andheri area of Mumbai. The deal could be worth Rs 350 crore (Rs 3.5 billion) in value, said sources close to the development.

Providence eyes exit from Idea

Providence eyes exit from Idea

Rediff.com   11 Jul 2011

Providence had bought 15 per cent in Idea Cellular in 2006 for around Rs 1,800 crore (Rs 18 billion) through its investment arm - P5 Asia Investment (Mauritius).

New market idiom: Question mark is a full stop!

New market idiom: Question mark is a full stop!

Rediff.com   8 Jul 2011

"The tacit understanding between people now is that a question should be looked upon as a statement," says an institutional dealer.

Actis to sell stake in Sterling Hospitals

Actis to sell stake in Sterling Hospitals

Rediff.com   20 Jun 2011

Six months after the Paras deal, Actis wants to exit Sterling Hospitals, a Gujarat-based multi-speciality hospital chain with six centres, according to three independent sources in the know.

India Inc takes cover to avoid Vodafone-like fate

India Inc takes cover to avoid Vodafone-like fate

Rediff.com   7 Jun 2011

Tax liability insurance is a key negotiation tool used by companies and advisers when a potential tax exposure has been identified and neither party is willing to bear the risk.

Sebi may tell NSDL to probe IPO scam

Sebi may tell NSDL to probe IPO scam

Rediff.com   31 May 2011

Decks being cleared to ensure that the Mohan Gopal report is restored in the June 27 board meeting.

JLR to source more parts from India

JLR to source more parts from India

Rediff.com   30 May 2011

The UK-based subsidiary of the Tatas is also keeping its options open for using its India assembly plants for manufacturing cars that can be exported to other countries.

Reckitt to sell Paras' personal care arm

Reckitt to sell Paras' personal care arm

Rediff.com   30 May 2011

The interested companies include Emami and Dabur.

Sebi members 'go slow' as their terms near end

Sebi members 'go slow' as their terms near end

Rediff.com   27 May 2011

Sebi whole-time members M S Sahoo and K M Abraham will both retire in July. While Sahoo's three-year tenure will end on July 13, Abraham will retire on July 21.

I-bankers can't ensure IPO success

I-bankers can't ensure IPO success

Rediff.com   25 May 2011

While listing can be good, success depends on sentiment and performance.

Sebi wants IPOs priced realistically

Sebi wants IPOs priced realistically

Rediff.com   28 Apr 2011

Financial year 2010-2011 saw high wealth erosion for investors in the IPO market.

Indian firms eye $2.5-bn US drug market

Indian firms eye $2.5-bn US drug market

Rediff.com   28 Apr 2011

The anti-depressant drug market in the US is primarily ruled by Effexor XR (Venlafaxine) of Wyeth (now owned by Pfizer).

Angel Broking looks to buy Sharekhan

Angel Broking looks to buy Sharekhan

Rediff.com   14 Apr 2011

If the deal materialises, Angel will have to pay at least Rs 800-1,000 crore (Rs 8-10 billion) for a 51 per cent stake, valuing the brokerage at Rs 1,500-2,000 crore (Rs 15-20 billion). The talks are at an early stage.